ClinicalTrials.govpublic full text
Safety and Efficacy Study of Ara-c at 18 gm/m2 Versus 12 gm/m2 for 3 Cycles Each in AML Consolidation
acute myeloid leukemia, aml, cytarabine dose, ara-c dose, consolidation, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 877917
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.